|

Finding Immune Nascent Type 1 Diabetes

RECRUITINGN/ASponsored by Indiana University
Actively Recruiting
PhaseN/A
SponsorIndiana University
Started2026-07-28
Est. completion2029-06
Eligibility
Age1 Year – 99 Years
Healthy vol.Accepted
Locations1 site

Summary

The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is: What form of recruitment communication is most effective for completing a type 1diabetes home screening kit? Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch). Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.

Eligibility

Age: 1 Year – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

* Participant must be in Indiana Biobank
* Participant must be able to provide consent
* Ages 1-99 including pregnant women

Exclusion Criteria:

* Refusal to sign informed consent for home screening is exclusionary for the home screening portion of the study
* While other medical conditions are allowable prior diabetes diagnosis is exclusionary for home autoantibody screening

Conditions3

DiabetesHealthy AdultType 1 Diabetes (T1D)

Locations1 site

Indiana University School of Medicine
Emily K Sims, MD

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.